Literature DB >> 27888680

Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program.

Amal Abdel-Baki1, Clairélaine Ouellet-Plamondon2, Émilie Salvat3, Kawthar Grar4, Stéphane Potvin5.   

Abstract

Substance use disorders (SUD) in first-episode psychosis (FEP) are highly prevalent and linked with poor outcomes. However, most longitudinal studies investigating their impacts in FEP have not reported proportions of patients who ceased SUD. Our aim was to examine the influence of SUD course on functional and symptomatic outcomes as well as service use in FEP. We performed a 2-year longitudinal study of 212 FEP patients, aged between 18 and 30 years, admitted to 2 early psychosis services in Montréal, Québec, Canada. We observed that cannabis was the first substance abused (42.9% at baseline), followed by alcohol (19.3%). The SUD rate decreased by approximately 30% during the first year. Patients with persistent SUD had worse functional outcomes (Quality of Life Scale, Social and Occupational Functioning Assessment Scale, employment), more symptoms (Positive and Negative Symptoms Scale) and heavier service use (emergency and hospitalization). SUD persistence was associated with illness severity, homelessness and cluster-B personality. Those living with their parents and financially supported by them were more likely to cease SUD. Our results indicate that SUD course was more significant than having SUD at admission; persistent SUD was associated with worse outcomes. SUD decreased during a general early psychosis intervention program (with no specialized SUD treatment). An integrated, specialized approach targeting FEP patients with predictive factors of SUD persistence during the first years of treatment might increase SUD cessation and possibly improve outcomes.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27888680     DOI: 10.1016/j.psychres.2016.11.007

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients.

Authors:  Vincent Ferraro; Simon Lafrenière; Marie-France Demers; Marc-André Roy; Amal Abdel-Baki
Journal:  Psychopharmacology (Berl)       Date:  2020-09-25       Impact factor: 4.530

2.  Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis.

Authors:  Sofia Medrano; Amal Abdel-Baki; Emmanuel Stip; Stéphane Potvin
Journal:  Psychopharmacol Bull       Date:  2018-06-20

Review 3.  The link between schizophrenia and substance use disorder: A unifying hypothesis.

Authors:  Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green
Journal:  Schizophr Res       Date:  2017-04-14       Impact factor: 4.939

4.  Predictors of functional status at service entry and discharge among young people with first episode psychosis.

Authors:  S M Cotton; M Lambert; B G Schimmelmann; K Filia; V Rayner; L Hides; D L Foley; A Ratheesh; A Watson; P Rodger; P D McGorry; P Conus
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-02-23       Impact factor: 4.328

5.  Barriers and Facilitators That Influence Providers' Ability to Educate, Monitor, and Treat Substance Use in First-Episode Psychosis Programs Using the Theoretical Domains Framework.

Authors:  Oladunni Oluwoye; Elizabeth Fraser
Journal:  Qual Health Res       Date:  2021-02-16

6.  A Retrospective Study of the Clinical Characteristics Associated with Alcohol and Cannabis use in Early Phase Psychosis.

Authors:  Jacob Cookey; Jacob McGavin; Candice E Crocker; Kara Matheson; Sherry H Stewart; Philip G Tibbo
Journal:  Can J Psychiatry       Date:  2020-02-04       Impact factor: 4.356

7.  Trajectories of occupational and social functioning in people with recent-onset non-affective psychosis enrolled in specialized early intervention services across New York state.

Authors:  Els van der Ven; Jennifer Scodes; Cale Basaraba; Luca Pauselli; Franco Mascayano; Ilana Nossel; Iruma Bello; Jennifer Humensky; Ezra Susser; Melanie Wall; Lisa Dixon
Journal:  Schizophr Res       Date:  2020-06-05       Impact factor: 4.939

8.  Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use.

Authors:  Ana Adan; Julia E Marquez-Arrico; Gail Gilchrist
Journal:  Health Qual Life Outcomes       Date:  2017-10-23       Impact factor: 3.186

9.  First-episode psychosis and substance use in Nelson Mandela Bay: Findings from an acute mental health unit.

Authors:  Yanga Thungana; Zukiswa Zingela; Stephan van Wyk
Journal:  S Afr J Psychiatr       Date:  2019-10-24       Impact factor: 1.550

Review 10.  Non-Genetic Factors in Schizophrenia.

Authors:  Simona A Stilo; Robin M Murray
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.